Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics

NCT03389321 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Riociguat (Adempas)
DRUG: Macitentan (Opsumit)

Sponsor

Actelion